218 related articles for article (PubMed ID: 32039388)
1. Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis.
Chen YY; Arndtz K; Webb G; Corrigan M; Akiror S; Liaskou E; Woodward P; Adams DH; Weston CJ; Hirschfield GM
JHEP Rep; 2019 Nov; 1(5):369-376. PubMed ID: 32039388
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis.
Reich M; Spomer L; Klindt C; Fuchs K; Stindt J; Deutschmann K; Höhne J; Liaskou E; Hov JR; Karlsen TH; Beuers U; Verheij J; Ferreira-Gonzalez S; Hirschfield G; Forbes SJ; Schramm C; Esposito I; Nierhoff D; Fickert P; Fuchs CD; Trauner M; García-Beccaria M; Gabernet G; Nahnsen S; Mallm JP; Vogel M; Schoonjans K; Lautwein T; Köhrer K; Häussinger D; Luedde T; Heikenwalder M; Keitel V
J Hepatol; 2021 Sep; 75(3):634-646. PubMed ID: 33872692
[TBL] [Abstract][Full Text] [Related]
3. Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice.
Guicciardi ME; Trussoni CE; Krishnan A; Bronk SF; Lorenzo Pisarello MJ; O'Hara SP; Splinter PL; Gao Y; Vig P; Revzin A; LaRusso NF; Gores GJ
J Hepatol; 2018 Sep; 69(3):676-686. PubMed ID: 29802947
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
5. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver.
Andrews TS; Nakib D; Perciani CT; Ma XZ; Liu L; Winter E; Camat D; Chung SW; Lumanto P; Manuel J; Mangroo S; Hansen B; Arpinder B; Thoeni C; Sayed B; Feld J; Gehring A; Gulamhusein A; Hirschfield GM; Ricciuto A; Bader GD; McGilvray ID; MacParland S
J Hepatol; 2024 May; 80(5):730-743. PubMed ID: 38199298
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin characterizes bile duct-associated macrophages and correlates with liver fibrosis severity in primary sclerosing cholangitis.
De Muynck K; Heyerick L; De Ponti FF; Vanderborght B; Meese T; Van Campenhout S; Baudonck L; Gijbels E; Rodrigues PM; Banales JM; Vesterhuus M; Folseraas T; Scott CL; Vinken M; Van der Linden M; Hoorens A; Van Dorpe J; Lefere S; Geerts A; Van Nieuwerburgh F; Verhelst X; Van Vlierberghe H; Devisscher L
Hepatology; 2024 Feb; 79(2):269-288. PubMed ID: 37535809
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis.
Müller AL; Casar C; Preti M; Krzikalla D; Gottwick C; Averhoff P; Rosenstiel P; Gelderblom M; Altfeld M; Lohse AW; Steinmann S; Sebode M; Krause J; Schwinge D; Schramm C; Carambia A; Herkel J
J Hepatol; 2022 Dec; 77(6):1532-1544. PubMed ID: 35798133
[TBL] [Abstract][Full Text] [Related]
8. Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.
Zimmermann HW; Seidler S; Nattermann J; Gassler N; Hellerbrand C; Zernecke A; Tischendorf JJ; Luedde T; Weiskirchen R; Trautwein C; Tacke F
PLoS One; 2010 Jun; 5(6):e11049. PubMed ID: 20548789
[TBL] [Abstract][Full Text] [Related]
9. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
[TBL] [Abstract][Full Text] [Related]
10. Mapping the hepatic immune landscape identifies monocytic macrophages as key drivers of steatohepatitis and cholangiopathy progression.
Guillot A; Winkler M; Silva Afonso M; Aggarwal A; Lopez D; Berger H; Kohlhepp MS; Liu H; Özdirik B; Eschrich J; Ma J; Peiseler M; Heymann F; Pendem S; Mahadevan S; Gao B; Diehl L; Gupta R; Tacke F
Hepatology; 2023 Jul; 78(1):150-166. PubMed ID: 36630995
[TBL] [Abstract][Full Text] [Related]
11. Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4
Poch T; Krause J; Casar C; Liwinski T; Glau L; Kaufmann M; Ahrenstorf AE; Hess LU; Ziegler AE; Martrus G; Lunemann S; Sebode M; Li J; Schwinge D; Krebs CF; Franke A; Friese MA; Oldhafer KJ; Fischer L; Altfeld M; Lohse AW; Huber S; Tolosa E; Gagliani N; Schramm C
J Hepatol; 2021 Aug; 75(2):414-423. PubMed ID: 33774059
[TBL] [Abstract][Full Text] [Related]
12. Liver fibrosis and CD206
Tan-Garcia A; Lai F; Sheng Yeong JP; Irac SE; Ng PY; Msallam R; Tatt Lim JC; Wai LE; Tham CYL; Choo SP; Lim T; Young DY; D'Ambrosio R; Degasperi E; Perbellini R; Newell E; Le Bert N; Ginhoux F; Bertoletti A; Chen Q; Dutertre CA
JHEP Rep; 2020 Feb; 2(1):100062. PubMed ID: 32039403
[TBL] [Abstract][Full Text] [Related]
13. Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis.
Trauner M; Gindin Y; Jiang Z; Chung C; Subramanian GM; Myers RP; Gulamhusein A; Kowdley KV; Levy C; Goodman Z; Manns MP; Muir AJ; Bowlus CL
JHEP Rep; 2020 Feb; 2(1):100060. PubMed ID: 32039401
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease.
Shearn CT; Orlicky DJ; Petersen DR
Exp Mol Pathol; 2018 Feb; 104(1):1-8. PubMed ID: 29180269
[TBL] [Abstract][Full Text] [Related]
15. Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis.
Braadland PR; Schneider KM; Bergquist A; Molinaro A; Lövgren-Sandblom A; Henricsson M; Karlsen TH; Vesterhus M; Trautwein C; Hov JR; Marschall HU
JHEP Rep; 2022 Nov; 4(11):100561. PubMed ID: 36176935
[TBL] [Abstract][Full Text] [Related]
16. TGR5: pathogenetic role and/or therapeutic target in fibrosing cholangitis?
Keitel V; Reich M; Häussinger D
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):218-25. PubMed ID: 25138774
[TBL] [Abstract][Full Text] [Related]
17. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Ahn DW
Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
[TBL] [Abstract][Full Text] [Related]
18. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
Nguyen L; Cazzagon N; Corpechot C; El Mouhadi S; Lemoinne S; Chazouillères O; Arrivé L
Eur Radiol; 2019 Mar; 29(3):1460-1468. PubMed ID: 30159619
[TBL] [Abstract][Full Text] [Related]
20. Monocytes as Potential Mediators of Pathogen-Induced T-Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC).
Kunzmann LK; Schoknecht T; Poch T; Henze L; Stein S; Kriz M; Grewe I; Preti M; Hartl J; Pannicke N; Peiseler M; Sebode M; Zenouzi R; Horvatits T; Böttcher M; Petersen BS; Weiler-Normann C; Hess LU; Ahrenstorf AE; Lunemann S; Martrus G; Fischer L; Li J; Carambia A; Kluwe J; Huber S; Lohse AW; Franke A; Herkel J; Schramm C; Schwinge D
Hepatology; 2020 Oct; 72(4):1310-1326. PubMed ID: 33090557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]